AGN

PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril

Pfizer missed on earnings, and PFE stock slipped as a result. But even if you don't own Pfizer, you don't want to ignore what's happening there.

7 Stocks to Sell After Hillary Clinton Wins

Hillary Clinton is the status quo candidate, but she has the biotech industry shaking in their lab coats. Sell these seven healthcare stocks!

7 Stocks That Could Be Bought Next

Traders looking for the next buyout target should keep a close eye on these seven stocks.

Allergan PLCā€™s Charm-and-Merger Offensive (AGN)

Allergan has switched strategies, and now wants to buy potential blockbuster drugs. But does AGN CEO Brent Saunders have an eye for the new game?

Allergan plc Ordinary Shares: What Is AGN Getting for Its Billion Dollars?

Allergen (AGN) is in a buying mood, and can afford to buy Tobira (TBRA). But, that doesn't mean there's a big payback for the investment.

Allergan plc Ordinary Shares (AGN) Up on $639M Buyout of Vitae Pharmaceuticals Inc (VTAE)

Allergan plc Ordinary Shares (NYSE:AGN) is buying Vitae Pharmaceuticals Inc. (NASDAQ:VTAE) to ramp up its dermatology treatment offerings.

GW Pharmaceuticals PLC- ADR (GWPH) Boards the Buyout Rumor Mill

GW Pharma (GWPH) is allegedly working with an investment bank after several companies expressed interest in a transaction.

PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business

Pfizer (PFE) has announced that it will be acquiring part of AstraZeneca's (AZN) antibiotic business outside the US for $725 million.

7 Stocks the Smart Money Loves … Or Hates

What is the smart money buying and selling lately? A look at the newest opinions on stocks like Apple, Facebook ... and an Irish aircraft leaser?

Why Allergan plc Ordinary Shares (AGN), AMN Healthcare Services, Inc. (AHS) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

Owners of Bristol-Myers Squibb (BMY), Allergan (AGN) and AMN Healthcare Services (AHS) are wishing the weekend lasted one more day today.

Allergan Plc: Will the Downtrend Continue for AGN Stock?

Despite chatter of a biotech acquisition and earnings Monday morning, the options market in AGN stock suggests normal event risk next week.

Biogen Inc (BIIB) Tacks on $7B in Market Value on Buyout Talk

Biogen IncĀ (NASDAQ:BIIB) just made a huge move out of thin air Tuesday evening, spiking 9.5% to $330 as of this writing. Until the surge, BIIB…

Carl Icahn Takes Stake in Allergan plc Ordinary Shares (AGN) Stock

Allergan stock was up on Tuesday after news that Carl Icahn had taken a 'large' stake in the company, but details weren't revealed.

The 10 Best Healthcare Stocks to Buy Now

These companies are 10 of the best healthcare stocks to buy right now, as they should outperform in 2016's second half thanks to a few near-term catalysts.

Allergan: Why the Earnings Rally Is WAY Overdone for AGN Stock

Allergan (AGN) stock is soaring on Tuesday after an earnings beat and announcement of a huge stock buyback. But the rally is WAY overdone.

Why Allergan plc (AGN), Krispy Kreme Doughnuts (KKD) and Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Are 3 of Today’s Best Stocks

Market gains were modest, but the real excitement came by way of AGN, KKD and TEVA, which were easily three of today's best stocks.

Is Pfizer Inc. Finally Safe To Buy Again? (PFE)

A first-quarter earnings and revenue beat has investors excited once again with formerly beat-down Pfizer Inc. Is now the time to buy PFE?

3 Big Pharma Stocks to Buy, 3 to Avoid

Big Pharma stocks are under pressure as regulation threatens to curb drug prices and tax driven mergers are intercepted by the treasury.

PFE Stock: Why the Pfizer Inc.-Allergan Plc Mega-Merger Got Murked (AGN)

What does it mean for PFE stock and Allergan (AGN) that the deal's been called off? Well, Pfizer especially has a lot more options now.